BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Prostate
,
Anticancer prodrugs
,
Fluoxetine
,
rs2300478
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Platelet-derived growth factor receptor alpha
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Peritoneum
Synovial membrane
Stomach fundus
Ovary
Stomach pyloric
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Eosinophilic disorder
Syndrome of infant of diabetic mother
Anomaly of chromosome pair 6
Urogenital injury
Adrenoleukodystrophy
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
icilin
2,4-Dinitrophenol
NVP-AEW541
Menthol
5-chloro-1-(4-chlorobenzyl)-3-(phenylthio)indole-2-carboxylic acid
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PQBP1
SOX5
RBM4
CLN3
ULK2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Lungs from mice overexpressing Nogo-B when challenged with lipopolysaccharide
Neocortical neurons of Swiss albino mouse embryos treated with high and low dose of lactacystin
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
OMIM - Eosinophilic disorder
OMIM - Malignant neoplasms
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Platelet-derived growth factor receptor alpha
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable K…
A Study of Olaratumab (IMC-3G3) in Prostate Cancer
Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).
A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastat…
Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ